Importance Prostate cancer is the most common cancer diagnosis made in men with more
than 160 000 new cases each year in the United States. Although it often has an indolent …

Nomograms are widely used as prognostic devices in oncology and medicine. With the
ability to generate an individual probability of a clinical event by integrating diverse …

Purpose: The summary presented herein represents Part I of the three-part series dedicated
to Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, discussing risk assessment …

Background In men with a detectable prostate-specific antigen (PSA) level after
prostatectomy for prostate cancer, salvage prostate bed radiotherapy (PBRT) results in …

Background Adjuvant radiotherapy has been shown to halve the risk of biochemical
progression for patients with high-risk disease after radical prostatectomy. Early salvage …

The NCCN Guidelines for Prostate Cancer include recommendations regarding diagnosis,
risk stratification and workup, treatment options for localized disease, and management of …

The NCCN Guidelines for Prostate Cancer address staging and risk assessment after an
initial diagnosis of prostate cancer and management options for localized, regional, and …

PURPOSE This guideline provides recommendations for available tissue-based prostate
cancer biomarkers geared toward patient selection for active surveillance, identification of …

In recent years, several new biomarkers supplementing the role of prostate-specific antigen
(PSA) have become available for men with prostate cancer. Although widely used in an ad …

To demonstrate that a biomarker is predictive of treatment benefit, the study requires
biomarker status on all patients as well as patients who were treated with the agent of …